CANbridge Pharmaceuticals Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
| Date | Value | Name | Entity | Role | Shares | Max Price |
|---|---|---|---|---|---|---|
| 19 Dec 23 | Sell€578,325 | RA Capital Management, L.P. | Company | 58,252,540 | €0.0099 | |
| 19 Dec 23 | Sell€38,848 | Farringdon Capital Management | Company | 3,913,050 | €0.0099 | |
| 15 Dec 23 | Buy€525,524 | Athos Capital Limited | Company | 52,665,590 | €0.01 |
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
| Owner Type | Number of Shares | Ownership Percentage |
|---|---|---|
| Public Companies | 20,554,860 | 4.84% |
| Institutions | 25,820,030 | 6.08% |
| VC/PE Firms | 32,829,330 | 7.73% |
| Individual Insiders | 42,561,246 | 10% |
| Hedge Funds | 49,313,414 | 11.6% |
| General Public | 253,759,440 | 59.7% |
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Top Shareholders
| Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
|---|---|---|---|---|---|---|
| 49,313,414 | €1.0m | 0% | 0.32% | |||
| 41,861,246 | €867.2k | 0.01% | no data | |||
| 32,829,330 | €680.1k | 0% | 0.06% | |||
| 20,554,860 | €425.8k | 0% | no data | |||
| 19,792,100 | €410.0k | 0% | 1.61% | |||
| 5,357,576 | €111.0k | 0% | 1.0% | |||
| 700,000 | €14.5k | 0% | no data | |||
| 560,354 | €11.6k | 0% | no data | |||
| 110,000 | €2.3k | 0% | no data |